NVCT- Nuvectis Pharma, Inc.

Name: Nuvectis Pharma, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Nuvectis Pharma, Inc. (NVCT) has 9 insiders with recent SEC Form 4 filings, including 20 buys and 0 sells. NVCT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Bentsur Ron	3.68M	$41.80M	-
10%	Mosseri Marlio Charles	3.14M	$35.66M	-
Other	Poradosu Enrique	1.81M	$20.54M	-
Other	Shemesh Shay	1.79M	$20.39M	-
VP	Carson Michael J.	200.1K	$2.28M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 5, 2025	Bentsur Ron64	Chairman &CEO	Buy	5,000	$5.72	$28,600.00	+0.1%	+50.1%	-
Nov 5, 2025	Kaplan Matthew L.	Director	Buy	11,000	$5.84	$64,240.00	+9.7%	+50.1%	-
Nov 5, 2025	Sanchez Juan	Director	Buy	13,000	$5.79	$75,270.00	+20.0%	+50.1%	-
Oct 27, 2025	Mosseri Marlio Charles	10% Owner	Buy	154,770	$6.18	$957,083.18	+1.7%	+29.9%	-
Jun 20, 2025	Mosseri Marlio Charles	10% Owner	Buy	5,603	$7.99	$44,767.97	+0.2%	-21.3%	-
Jun 18, 2025	Mosseri Marlio Charles	10% Owner	Buy	33,442	$8.06	$269,532.04	+0.6%	-22.9%	-
May 12, 2025	Mosseri Marlio Charles	10% Owner	Buy	21,167	$8.11	$171,664.37	+0.7%	-26.9%	-
May 8, 2025	Mosseri Marlio Charles	10% Owner	Buy	27,411	$8.60	$235,647.22	+0.1%	-29.9%	-
Feb 7, 2025	Mosseri Marlio Charles	10% Owner	Buy	240,000	$5.00	$1,200,000.00	+9.1%	+37.4%	+32.5%
Dec 24, 2024	Bentsur Ron64	Chairman &CEO	Buy	4,500	$4.65	$20,925.00	+0.1%	+111.0%	+65.8%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC